Brief: Puretech Founded Entity Vor Bio Announces Exclusive Global License Agreement With Remegen For Late-Stage Autoimmune Asset
26/06/2025 07:46
June 26 (Reuters) - PureTech Health PLC PRTC.L: PURETECH FOUNDED ENTITY VOR BIO ANNOUNCES EXCLUSIVE GLOBAL LICENSE AGREEMENT WITH REMEGEN FOR LATE-STAGE AUTOIMMUNE ASSET AND $175 MILLION PRIVATE PLACEMENT PURETECH HEALTH PLC - VOR BIO TO PAY REMEGEN $125 MILLION Source text: ID:nBwTKq4Pa Further company coverage: PRTC.L ((( Reuters.Briefs@thomsonreuters.com );))